Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 14.72% is 52% above its 5-year average of 9.69%, near the high end of its 5-year range (3.41%–16.88%).
As of the fiscal period ended Saturday, July 4, 2026. 5.43% below its 12-month average of 15.57%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-07-04): 14.72%.
DEBT TO ASSETS RATIO
14.72%
DEBT TO ASSETS RATIO AVG TTM
15.57%
DEBT TO ASSETS RATIO AVG 3Y
13.08%
DEBT TO ASSETS RATIO AVG 5Y
9.69%
DEBT TO ASSETS RATIO AVG 10Y
8.10%
DEBT TO ASSETS RATIO AVG 15Y
5.40%
DEBT TO ASSETS RATIO AVG 20Y
6.54%
CURRENT VS TTM AVG
-5.43%
CURRENT VS 3Y AVG
+12.54%
CURRENT VS 5Y AVG
+51.98%
CURRENT VS 10Y AVG
+81.86%
CURRENT VS 15Y AVG
+172.79%
CURRENT VS 20Y AVG
+125.27%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 597 covered companies
CURRENT VS SECTOR MEDIAN
+14622.28%
vs the sector median at left
IRIDEX Corporation
Market Cap
$12.41M
Debt to Assets Ratio
14.72%
TTM Avg
15.57%
3Y Avg
13.08%
5Y Avg
9.69%
Market Cap
$12.46M
Debt to Assets Ratio
0.30%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.94M
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.87M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.75M
Debt to Assets Ratio
0.69%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.50M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.50M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.41M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.38M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IRIDEX Corporation (IRIX) | $12.41M | 14.72% | 15.57% | 13.08% | 9.69% |
| Dare Bioscience, Inc. (DARE)vs › | $12.46M | 0.30% | N/A | N/A | N/A |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.94M | 0.04% | N/A | N/A | N/A |
| Lantern Pharma Inc. (LTRN)vs › | $11.87M | 0.00% | N/A | N/A | N/A |
| Cytosorbents Corporation (CTSO)vs › | $11.75M | 0.69% | N/A | N/A | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.50M | 0.00% | N/A | N/A | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.50M | 0.01% | N/A | N/A | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $13.41M | 0.00% | N/A | N/A | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.38M | 0.00% | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.17M | 0.01% | N/A | N/A | N/A |
Debt/Assets
14.7%
Debt/Equity
1.10
Current Ratio
1.82
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-07-04 | 14.72% |
| 2026-04-04 | 15.12% |
| 2026-01-03 | 15.55% |
| 2025-09-27 | 16.88% |
| 2025-06-28 | 16.05% |
| 2025-03-29 | 15.48% |
| 2024-12-31 | 15.94% |
| 2024-09-28 | 16.28% |
| 2024-06-29 | 7.33% |
| 2024-03-30 | 7.39% |
| 2023-12-31 | 7.97% |
| 2023-09-30 | 8.29% |
| 2023-07-01 | 3.41% |
| 2023-04-01 | 3.70% |
| 2022-12-31 | 4.18% |
| 2022-10-01 | 4.39% |
| 2022-07-02 | 4.85% |
| 2022-04-02 | 5.03% |
| 2021-12-31 | 5.46% |
| 2021-10-02 | 5.72% |
| 2021-07-03 | 5.92% |
| 2021-04-03 | 7.94% |
| 2020-12-31 | 14.97% |
| 2020-09-26 | 15.81% |
| 2020-06-27 | 17.11% |
| 2020-03-28 | 9.28% |
| 2019-12-31 | 9.22% |
| 2019-09-28 | 15.82% |
| 2019-06-29 | 16.62% |
| 2019-03-30 | 17.39% |
| 2018-12-31 | 0.00% |
| 2018-09-29 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-07-01 | 0.00% |
| 2017-04-01 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-10-01 | 0.00% |
| 2016-07-02 | 0.00% |
| 2016-04-02 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-10-03 | 0.00% |
| 2015-07-04 | 0.00% |
| 2015-04-04 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-27 | 0.00% |
| 2014-06-28 | 0.00% |
| 2014-03-29 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-28 | 0.00% |
| 2013-06-29 | 0.00% |
| 2013-03-30 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-29 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-10-01 | 0.00% |
| 2011-07-02 | 0.00% |
| 2011-04-02 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-10-02 | 0.00% |
| 2010-07-03 | 0.00% |
| 2010-04-03 | 0.00% |
| 2009-12-31 | 12.44% |
| 2009-10-03 | 12.81% |
| 2009-07-04 | 16.64% |
| 2009-04-04 | 19.87% |
| 2008-12-31 | 21.26% |
| 2008-09-27 | 16.78% |
| 2008-06-28 | 15.43% |
| 2008-03-29 | 13.23% |
| 2007-12-31 | 21.18% |
| 2007-09-29 | 17.21% |
| 2007-06-30 | 14.88% |
| 2007-03-31 | 17.29% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-07-01 | 0.00% |
| 2006-04-01 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-10-01 | 0.00% |
| 2005-07-02 | 0.00% |
| 2005-04-02 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-10-02 | 0.00% |
| 2004-07-03 | 0.00% |
| 2004-04-03 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-27 | 0.00% |
| 2003-06-28 | 0.00% |
| 2003-03-29 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-28 | 0.00% |
